On the other hand, detection of OMD on PSMA-PET/CT was significantly higher in patients presenting BCR before salvage treatment compared to those with BCR after salvage treatment (86% vs. 61% of all positive PSMA-PET/CT, respectively, p = 0.02). The gene discussed is BCR; the disease is occult macular dystrophy.